• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Jul 11;14(1):16000.
doi: 10.1038/s41598-024-66885-2. Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile

Karen Y Oróstica[SUP] #[/SUP][SUP] 1 [/SUP], Sebastian B Mohr[SUP] #[/SUP][SUP] 2 3 [/SUP], Jonas Dehning[SUP] #[/SUP][SUP] 2 3 [/SUP], Simon Bauer[SUP] 2 [/SUP], David Medina-Ortiz[SUP] 4 [/SUP], Emil N Iftekhar[SUP] 2 3 [/SUP], Karen Mujica[SUP] 5 [/SUP], Paulo C Covarrubias[SUP] 5 [/SUP], Soledad Ulloa[SUP] 5 [/SUP], Andrés E Castillo[SUP] 5 [/SUP], Anamaría Daza-Sánchez[SUP] 6 [/SUP], Ricardo A Verdugo[SUP] 1 7 [/SUP], Jorge Fernández[SUP] 5 [/SUP], Álvaro Olivera-Nappa[SUP] 6 8 [/SUP], Viola Priesemann[SUP] 2 3 [/SUP], Seba Contreras[SUP] #[/SUP][SUP] 9 10 [/SUP]



Affiliations
Abstract

Genomic surveillance (GS) programmes were crucial in identifying and quantifying the mutating patterns of SARS-CoV-2 during the COVID-19 pandemic. In this work, we develop a Bayesian framework to quantify the relative transmissibility of different variants tailored for regions with limited GS. We use it to study the relative transmissibility of SARS-CoV-2 variants in Chile. Among the 3443 SARS-CoV-2 genomes collected between January and June 2021, where sampling was designed to be representative, the Gamma (P.1), Lambda (C.37), Alpha (B.1.1.7), B.1.1.348, and B.1.1 lineages were predominant. We found that Lambda and Gamma variants' reproduction numbers were 5% (95% CI: [1%, 14%]) and 16% (95% CI: [11%, 21%]) larger than Alpha's, respectively. Besides, we observed a systematic mutation enrichment in the Spike gene for all circulating variants, which strongly correlated with variants' transmissibility during the studied period (r = 0.93, p-value = 0.025). We also characterised the mutational signatures of local samples and their evolution over time and with the progress of vaccination, comparing them with those of samples collected in other regions worldwide. Altogether, our work provides a reliable method for quantifying variant transmissibility under subsampling and emphasises the importance of continuous genomic surveillance.


 
Back
Top Bottom